164 related articles for article (PubMed ID: 21525187)
1. Different patterns of mast cells distinguish diffuse from encapsulated neurofibromas in patients with neurofibromatosis 1.
Tucker T; Riccardi VM; Sutcliffe M; Vielkind J; Wechsler J; Wolkenstein P; Friedman JM
J Histochem Cytochem; 2011 Jun; 59(6):584-90. PubMed ID: 21525187
[TBL] [Abstract][Full Text] [Related]
2. S100B and neurofibromin immunostaining and X-inactivation patterns of laser-microdissected cells indicate a multicellular origin of some NF1-associated neurofibromas.
Tucker T; Riccardi VM; Brown C; Fee J; Sutcliffe M; Vielkind J; Wechsler J; Wolkenstein P; Friedman JM
J Neurosci Res; 2011 Sep; 89(9):1451-60. PubMed ID: 21674567
[TBL] [Abstract][Full Text] [Related]
3. Semiquantitative aspects of mast cells in normal skin and in neurofibromas of neurofibromatosis types 1 and 5.
Nürnberger M; Moll I
Dermatology; 1994; 188(4):296-9. PubMed ID: 8193404
[TBL] [Abstract][Full Text] [Related]
4. Mast Cells in Human Cutaneous Neurofibromas: Density, Subtypes, and Association with Clinical Features in Neurofibromatosis 1.
Kallionpää RA; Ahramo K; Martikkala E; Fazeli E; Haapaniemi P; Rokka A; Leivo I; Harvima IT; Peltonen J; Peltonen S
Dermatology; 2022; 238(2):329-339. PubMed ID: 34237737
[TBL] [Abstract][Full Text] [Related]
5. Vascular wall cells contribute to tumourigenesis in cutaneous neurofibromas of patients with neurofibromatosis type 1. A comparative histological, ultrastructural and immunohistochemical study.
Friedrich RE; Holstein AF; Middendorff R; Davidoff MS
Anticancer Res; 2012 May; 32(5):2139-58. PubMed ID: 22593502
[TBL] [Abstract][Full Text] [Related]
6. Neurofibromas in NF1: Schwann cell origin and role of tumor environment.
Zhu Y; Ghosh P; Charnay P; Burns DK; Parada LF
Science; 2002 May; 296(5569):920-2. PubMed ID: 11988578
[TBL] [Abstract][Full Text] [Related]
7. Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.
Yang FC; Chen S; Clegg T; Li X; Morgan T; Estwick SA; Yuan J; Khalaf W; Burgin S; Travers J; Parada LF; Ingram DA; Clapp DW
Hum Mol Genet; 2006 Aug; 15(16):2421-37. PubMed ID: 16835260
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and clinicopathological characteristics of lipomatous neurofibromas in neurofibromatosis 1: An investigation of 229 cutaneous neurofibromas and a systematic review of the literature.
Rozza-de-Menezes RE; Brum CAI; Gaglionone NC; de Sousa Almeida LM; Andrade-Losso RM; Paiva BVB; Faveret PLS; da Silva AV; Siqueira OHK; Riccardi VM; Cunha KS
J Cutan Pathol; 2018 Oct; 45(10):743-753. PubMed ID: 29959804
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of mast cell and microvascular densities in malignant peripheral nerve sheath tumor with and without neurofibromatosis type 1.
Vasconcelos RAT; Guimarães Coscarelli P; Vieira TM; Noguera WS; Rapozo DCM; Acioly MA
Cancer Med; 2019 Mar; 8(3):972-981. PubMed ID: 30735009
[TBL] [Abstract][Full Text] [Related]
10.
Chaney KE; Perrino MR; Kershner LJ; Patel AV; Wu J; Choi K; Rizvi TA; Dombi E; Szabo S; Largaespada DA; Ratner N
Cancer Res; 2020 Nov; 80(21):4720-4730. PubMed ID: 32816910
[TBL] [Abstract][Full Text] [Related]
11. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.
Mashour GA; Ratner N; Khan GA; Wang HL; Martuza RL; Kurtz A
Oncogene; 2001 Jan; 20(1):97-105. PubMed ID: 11244508
[TBL] [Abstract][Full Text] [Related]
12. Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors.
Beert E; Brems H; Daniëls B; De Wever I; Van Calenbergh F; Schoenaers J; Debiec-Rychter M; Gevaert O; De Raedt T; Van Den Bruel A; de Ravel T; Cichowski K; Kluwe L; Mautner V; Sciot R; Legius E
Genes Chromosomes Cancer; 2011 Dec; 50(12):1021-32. PubMed ID: 21987445
[TBL] [Abstract][Full Text] [Related]
13. Heightened CXCR4 and CXCL12 expression in NF1-associated neurofibromas.
Karaosmanoglu B; Kocaefe ÇY; Söylemezoğlu F; Anlar B; Varan A; Vargel İ; Ayter S
Childs Nerv Syst; 2018 May; 34(5):877-882. PubMed ID: 29455242
[TBL] [Abstract][Full Text] [Related]
14. Is the distribution of dermal neurofibromas in neurofibromatosis type 1 (NF1) related to the pattern of the skin surface temperature?
Kaufmann D; Tinschert S; Algermissen B
Eur J Dermatol; 2001; 11(6):521-6. PubMed ID: 11701400
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression.
Staser K; Yang FC; Clapp DW
Annu Rev Pathol; 2012; 7():469-95. PubMed ID: 22077553
[TBL] [Abstract][Full Text] [Related]
16. Nestin-positive stem cells in neurofibromas from patients with neurofibromatosis type 1-tumorigenic or incidental?
Pongpudpunth M; Bhawan J; Al-Natour SH; Mahalingam M
Am J Dermatopathol; 2010 Aug; 32(6):574-7. PubMed ID: 20520523
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history study.
Cannon A; Chen MJ; Li P; Boyd KP; Theos A; Redden DT; Korf B
Orphanet J Rare Dis; 2018 Feb; 13(1):31. PubMed ID: 29415745
[TBL] [Abstract][Full Text] [Related]
18. Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene.
Däschner K; Assum G; Eisenbarth I; Krone W; Hoffmeyer S; Wortmann S; Heymer B; Kehrer-Sawatzki H
Biochem Biophys Res Commun; 1997 May; 234(2):346-50. PubMed ID: 9177273
[TBL] [Abstract][Full Text] [Related]
19. Mast cells in benign nerve sheath tumours.
Isaacson P
J Pathol; 1976 Aug; 119(4):193-6. PubMed ID: 822142
[TBL] [Abstract][Full Text] [Related]
20. Molecular, genetic, and cellular pathogenesis of neurofibromas and surgical implications.
Gottfried ON; Viskochil DH; Fults DW; Couldwell WT
Neurosurgery; 2006 Jan; 58(1):1-16; discussion 1-16. PubMed ID: 16385324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
